Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-20-017732)

Filing Details

Accession Number:: 0001209191-20-017732
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-03-10 17:00:20
Reporting Period:: 2020-03-04

Accepted Time:: 2020-03-10 17:00:20
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1651311	Merus N.v.	MRUS	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1790357	Mark Throsby	C/O Merus N.v. Yalelaan 62 Utrecht P7 3584 CM	Evp & Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Disposition	2020-03-04	368	$18.10	44,155	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan.
Amount represents the weighted average price of shares sold, which ranged from $17.73 to $18.19. Details of individual transactions are available upon request.